Search
-
Explore how we use chemotherapy, including hepatic arterial infusion therapy, to treat primary liver cancer.
… Chemotherapy uses chemical substances to destroy cancer cells wherever they are in the body. Depending on your particular situation, we may recommend chemotherapy before surgery to help shrink your liver tumor. This is called adjuvant therapy . Chemotherapy can also help in lowering the risk that the
-
Video
… Session 2: Implications of CH Beyond Leukemia Moderator: Benjamin Ebert, MD, PhD Date : Wednesday, May 27, 2020 Time: 10:30 am - 11:15 am EST Cynthia Dunbar, MD, National Institutes of Health Natural and CRISPR-generated models of clonal hematopoiesis biology and interventions in non-human primates
-
The John Maciejowski Lab
… Job Title Graduate Student Education BS, Trinity College Mentor John Maciejowski Start Year 2017 Email [email protected]
-
About Herbs
Sheng Mai Yin is a TCM formula used to treat fatigue and cardiovascular disease.
… Common Name Sheng Mai San, Sheng Mai Pian, Shengmai Injection, Shenmai Injection, Restore the Pulse Formula, Pulse Generator What is it? Sheng Mai Yin (SMY) is a traditional Chinese medicine (TCM) formula. It’s made up of three different herbs. What are the potential uses and benefits? Sheng Mai Yin
-
News
Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers questions about diet, supplements, and what the research shows.
… Monday, September 30, 2024 Magnesium is having a big moment, as its boosters take to social media to tout the mineral’s potential to do everything from relieve anxiety and facilitate sleep to lower blood pressure and cure constipation. Naturally abundant in certain foods and widely available in supplement
-
The Radiation Core provides two animal irradiators and two cell/tissue irradiators for use in research.
… Two animal irradiators and two cell/tissue irradiators for use in research are available through the Radiation Core Facility. The irradiators are made available on a self-use basis to investigators at Memorial Sloan Kettering and by special permission to investigators from Weill Cornell Medical College
-
News
Researchers from MSK presented promising studies on treating rare solid tumors including mesothelioma and three types of soft-tissue at the annual meeting of the American Society of Clinical Oncology.
… Monday, June 3, 2024 Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented several promising studies on treating rare solid tumors at the annual meeting of the American Society of Clinical Oncology (ASCO). The results of clinical trials focused on mesothelioma and three types of soft-tissue
-
Acute myeloid leukemia (AML) is one of the most common leukemias in adults. Learn more about AML and how it’s diagnosed.
… Acute myeloid leukemia (AML), one of the most common leukemias in adults, is diagnosed in about 20,000 people in the United States each year. The average age at diagnosis is 72. The disease affects more men than women. New Patient Appointments Call 646-497-9154 We’re available 24 hours a day, 7 days
-
La leucemia mieloide aguda (LMA) es una de las leucemias más comunes en los adultos. Obtenga más información sobre la leucemia mieloide aguda y cómo se diagnostica.
… La leucemia mieloide aguda (LMA), una de las leucemias más comunes en adultos, se diagnostica en aproximadamente 20,000 personas en los Estados Unidos cada año. La edad promedio en el momento del diagnóstico es de 72 años. La enfermedad afecta más a hombres que a mujeres. New Patient Appointments Call
-
News
Learn how a new cancer engineering PhD program is attracting leading scientists to come to MSK.
… Friday, September 13, 2024 A visionary new approach to solving problems in cancer science is now fully underway at Memorial Sloan Kettering Cancer Center (MSK), as the inaugural class begins the Pat and Ian Cook Doctoral Program in Cancer Engineering . Leading researchers — drawn to MSK by the opportunity